451
|
Noninvasive PET Imaging of a Ga-68-Radiolabeled RRL-Derived Peptide in Hepatocarcinoma Murine Models. Mol Imaging Biol 2018; 21:286-296. [PMID: 29916116 DOI: 10.1007/s11307-018-1234-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
PURPOSE Tc-99m- and I-131-labeled arginine-arginine-leucine (RRL) peptides have shown the feasibility of tumor imaging in our previous studies. However, there have been no reports using RRL peptide for positron emission tomography (PET) imaging. In this study, RRL was radiolabeled with Ga-68 under optimized reaction conditions to develop a better specific and effective tumor imaging agent. PROCEDURES RRL was synthesized and conjugated to a bifunctional chelating agent (DOTA-NHS), then radiolabeled with Ga-68. Labeling yield was optimized by varying pH, temperature, and reaction time and the stability was evaluated in human fresh serum. Cellular uptakes of [68Ga]DOTA-RRL and FITC-conjugated RRL in HepG2 cells were evaluated using a gamma counter, confocal microscopy, and flow cytometry. PET images and biodistribution were performed in HepG2 tumor-bearing mice after injection of [68Ga]DOTA-RRL or [68Ga]GaCl3 at different time points. Further, blocking study was investigated using cold RRL. RESULTS The labeling yield of [68Ga]DOTA-RRL was 80.6 ± 3.9 % with a pH of 3.5-4.5 at 100 °C for 15 min. The cellular uptake of [68Ga]DOTA-RRL in HepG2 cells was significantly higher than that of [68Ga]GaCl3 (P < 0.05). Moreover, the high fluorescent affinity of FITC-conjugated RRL in HepG2 cells was shown using confocal microscopy and flow cytometry. After injection of [68Ga]DOTA-RRL in HepG2 tumor-bearing mice, tumor regions exhibited high radioactive accumulation over 120 min and the highest uptake at 30 min. After blocked with cold RRL, HepG2 tumors could not be visualized. [68Ga]GaCl3 was unable to show tumor images at any time point. The biodistribution results confirmed the PET imaging and blocking results. CONCLUSIONS Our study successfully prepared [68Ga]DOTA-RRL with a high labeling yield under the optimized reaction conditions and demonstrated its potential role as a PET imaging agent for tumor-targeted diagnosis.
Collapse
|
452
|
Guan SS, Wu CT, Chiu CY, Luo TY, Wu JY, Liao TZ, Liu SH. Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo. J Transl Med 2018; 16:168. [PMID: 29921305 PMCID: PMC6009821 DOI: 10.1186/s12967-018-1550-3] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Accepted: 06/15/2018] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND The human epidermal growth factor receptor 2 (HER2) involved proliferation, angiogenesis, and reduced apoptosis in gastric cancer (GC), which is a common target for tumor therapy. HER2 is usually overexpressed in more than 15% GC patients, developing a reliable diagnostic tool for tumor HER2 detection is important. In this study, we attend to use polyethylene glycol (PEG) linked anti-HER2/neu peptide (AHNP-PEG) as a nuclear imaging agent probe for HER2 detection in GC xenograft animal model. METHODS The HER2 expression of human sera and tissues were detected in GC patients and normal subjects. GC cell lines NCI-N87 (high HER2 levels) and MKN45 (low HER2 levels) were treated with AHNP-PEG to assess the cell viability and HER2 binding ability. The NCI-N87 was treated with AHNP-PEG to observe the level and phosphorylation of HER2. The MKN45 and NCI-N87-induced xenograft mice were intravenous injection with fluorescence labeled AHNP-PEG for detecting in vivo fluorescence imaging properties and biodistribution. The AHNP-PEG was conjugated with diethylenetriaminopentaacetic acid (DTPA) for indium-111 labeling (111In-DTPA-AHNP-PEG). The stability of was assessed in vitro. The imaging properties and biodistribution of 111In-DTPA-AHNP-PEG were observed in NCI-N87-induced xenograft mice. RESULTS The serum HER2 (sHER2) levels in GC patients were significantly higher than the normal subjects. The sHER2 levels were correlated with the tumor HER2 levels in different stages of GC patients. The AHNP-PEG inhibited the cell growth and down-regulated HER2 phosphorylation in HER2-overexpressed human GC cells (NCI-N87) via specific HER2 interaction of cell surface. In addition, the GC tumor tissues from HER2-postive xenograft mice presented higher HER2 fluorescence imaging as compared to HER2-negative group. The HER2 levels in the tumor tissues were also higher than other organs in NCI-N87-induced xenograft mice. Finally, we further observed that the 111In-DTPA-AHNP-PEG was significantly enhanced in tumor tissues of NCI-N87-induced xenograft mice compared to control. CONCLUSIONS These findings suggest that the sHER2 measurement may be as a potential tool for detecting HER2 expressions in GC patients. The radioisotope-labeled AHNP-PEG may be useful to apply in GC patients for HER2 nuclear medicine imaging.
Collapse
Affiliation(s)
- Siao-Syun Guan
- Institute of Nuclear Energy Research, Atomic Energy Council, Taoyuan, Taiwan
| | - Cheng-Tien Wu
- Institute of Toxicology, College of Medicine, National Taiwan University, No. 1, Section 1, Jen-Ai Road, Taipei, 10051, Taiwan
| | - Chen-Yuan Chiu
- Institute of Food Safety and Health, College of Public Health, National Taiwan University, Taipei, Taiwan
| | - Tsai-Yueh Luo
- Institute of Nuclear Energy Research, Atomic Energy Council, Taoyuan, Taiwan
| | - Jeng-Yih Wu
- Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
| | - Tse-Zung Liao
- Institute of Nuclear Energy Research, Atomic Energy Council, Taoyuan, Taiwan
| | - Shing-Hwa Liu
- Institute of Toxicology, College of Medicine, National Taiwan University, No. 1, Section 1, Jen-Ai Road, Taipei, 10051, Taiwan. .,Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan. .,Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
| |
Collapse
|
453
|
Thiele NA, Wilson JJ. Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches. Cancer Biother Radiopharm 2018; 33:336-348. [PMID: 29889562 DOI: 10.1089/cbr.2018.2494] [Citation(s) in RCA: 80] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
The α-emitting radionuclide actinium-225 possesses nuclear properties that are highly promising for use in targeted α therapy (TAT), a therapeutic strategy that employs α particle emissions to destroy tumors. A key factor, however, that may hinder the clinical use of actinium-225 is the poor understanding of its coordination chemistry, which creates challenges for the development of suitable chelation strategies for this ion. In this article, we provide an overview of the known chemistry of actinium and a summary of the chelating agents that have been explored for use in actinium-225-based TAT. This overview provides a starting point for researchers in the field of TAT to gain an understanding of this valuable therapeutic radionuclide.
Collapse
Affiliation(s)
- Nikki A Thiele
- Department of Chemistry and Chemical Biology, Cornell University , Ithaca, New York
| | - Justin J Wilson
- Department of Chemistry and Chemical Biology, Cornell University , Ithaca, New York
| |
Collapse
|
454
|
Tsebrikova GS, Polyakova IN, Solov'ev VP, Ivanova IS, Kalashnikova IP, Kodina GE, Baulin VE, Tsivadze AY. Complexation of the new tetrakis[methyl(diphenylphosphorylated)] cyclen derivative with transition metals: First examples of octacoordinate zinc(II) and cobalt(II) complexes with cyclen molecules. Inorganica Chim Acta 2018. [DOI: 10.1016/j.ica.2018.04.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
455
|
Licciardello N, Hunoldt S, Bergmann R, Singh G, Mamat C, Faramus A, Ddungu JLZ, Silvestrini S, Maggini M, De Cola L, Stephan H. Biodistribution studies of ultrasmall silicon nanoparticles and carbon dots in experimental rats and tumor mice. NANOSCALE 2018; 10:9880-9891. [PMID: 29658023 DOI: 10.1039/c8nr01063c] [Citation(s) in RCA: 41] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Ultrasmall clearable nanoparticles possess enormous potential as cancer imaging agents. In particular, biocompatible silicon nanoparticles (Si NPs) and carbon quantum dots (CQDs) hold great potential in this regard. Their facile surface functionalization easily allows the introduction of different labels for in vivo imaging. However, to date, a thorough biodistribution study by in vivo positron emission tomography (PET) and a comparative study of Si vs. C particles of similar size are missing. In this contribution, ultrasmall (size <5 nm) Si NPs and CQDs were synthesized and characterized by high-resolution transmission electron microscopy (HR-TEM), Fourier-transform infrared (FTIR), absorption and steady-state emission spectroscopy. Subsequent functionalization of NPs with a near-infrared dye (Kodak-XS-670) or a radiolabel (64Cu) enabled a detailed in vitro and in vivo study of the particles. For radiolabeling experiments, the bifunctional chelating agent S-2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (p-SCN-Bn-NOTA) was conjugated to the amino surface groups of the respective NPs. Efficient radiolabeling of NOTA-functionalized NPs with the positron emitter 64Cu was found. The biodistribution and PET studies showed a rapid renal clearance from the in vivo systems for both variants of the nanoparticles. Interestingly, the different derivatives investigated exhibited significant differences in the biodistribution and pharmacokinetic properties. This can mostly be attributed to different surface charge and hydrophilicity of the NPs, arising from the synthetic strategy used to prepare the particles.
Collapse
Affiliation(s)
- Nadia Licciardello
- Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden - Rossendorf, Bautzner Landstraße 400, D-01328 Dresden, Germany.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
456
|
Salvé M, Avohou HT, Monbaliu JCM, Lebrun P, Lemaire C, Damblon C, de Tullio P, Hubert P, Hustinx R, Luxen A. "NOTA-PRGD 2 and NODAGA-PRGD 2 : Bioconjugation, characterization, radiolabelling, and design space". J Labelled Comp Radiopharm 2018; 61:487-500. [PMID: 29430693 DOI: 10.1002/jlcr.3613] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2017] [Revised: 01/29/2018] [Accepted: 01/29/2018] [Indexed: 12/13/2022]
Abstract
This work reports on the development of amide bond bioconjugation for the production of -NOTA and -NODAGA PRGD2 using batch strategy and microfluidic reactor technology. The final radiolabelling step was fully optimized using Design of Experiments and Design Space approaches, hence targeting robust labelling yields in routine. Optimal labelling conditions were defined in sodium acetate buffer as 168 μg/mL peptide concentration, 4.9 pH, 47.5°C temperature, and 12.5-minute reaction time. Upon optimization, the Gallium-68 radiolabelling was fully automated. All the work was designed to be compliant to the GMP environment and to support the pharmaceutical scale-up.
Collapse
Affiliation(s)
- Mallory Salvé
- GIGA-CRC In VIVO Imaging, University of Liège, Liège, Belgium.,Nuclear Medicine and Oncological Imaging Division, CHU of Liege, Liège, Belgium
| | - Hermane T Avohou
- Center for Interdisciplinary Research on Medicines, University of Liège, Liège, Belgium
| | | | - Pierre Lebrun
- Pharmalex Statistical Solution, Mont-Saint-Guibert, Belgium
| | | | | | - Pascal de Tullio
- Center for Interdisciplinary Research on Medicines, University of Liège, Liège, Belgium
| | - Philippe Hubert
- Center for Interdisciplinary Research on Medicines, University of Liège, Liège, Belgium
| | - Roland Hustinx
- GIGA-CRC In VIVO Imaging, University of Liège, Liège, Belgium.,Nuclear Medicine and Oncological Imaging Division, CHU of Liege, Liège, Belgium
| | - André Luxen
- GIGA-CRC In VIVO Imaging, University of Liège, Liège, Belgium
| |
Collapse
|
457
|
Le Fur M, Molnár E, Beyler M, Fougère O, Esteban-Gómez D, Rousseaux O, Tripier R, Tircsó G, Platas-Iglesias C. Expanding the Family of Pyclen-Based Ligands Bearing Pendant Picolinate Arms for Lanthanide Complexation. Inorg Chem 2018; 57:6932-6945. [DOI: 10.1021/acs.inorgchem.8b00598] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- Mariane Le Fur
- Université de Bretagne Occidentale, UMR-CNRS 6521, IBSAM, UFR des Sciences et Techniques, 6 avenue Victor le Gorgeu, C.S. 93837, 29238 Brest Cedex 3, France
| | - Enikő Molnár
- Department of Inorganic and Analytical Chemistry, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary
| | - Maryline Beyler
- Université de Bretagne Occidentale, UMR-CNRS 6521, IBSAM, UFR des Sciences et Techniques, 6 avenue Victor le Gorgeu, C.S. 93837, 29238 Brest Cedex 3, France
| | - Olivier Fougère
- Groupe Guerbet,
Centre de Recherche d’Aulnay-sous-Bois, BP 57400, 95943 Roissy CdG Cedex, France
| | - David Esteban-Gómez
- Departamento de Química, Facultade de Ciencias & Centro de Investigaciones Científicas Avanzadas (CICA), Universidade da Coruña, 15071 A Coruña, Spain
| | - Olivier Rousseaux
- Groupe Guerbet,
Centre de Recherche d’Aulnay-sous-Bois, BP 57400, 95943 Roissy CdG Cedex, France
| | - Raphaël Tripier
- Université de Bretagne Occidentale, UMR-CNRS 6521, IBSAM, UFR des Sciences et Techniques, 6 avenue Victor le Gorgeu, C.S. 93837, 29238 Brest Cedex 3, France
| | - Gyula Tircsó
- Department of Inorganic and Analytical Chemistry, Faculty of Science and Technology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary
| | - Carlos Platas-Iglesias
- Departamento de Química, Facultade de Ciencias & Centro de Investigaciones Científicas Avanzadas (CICA), Universidade da Coruña, 15071 A Coruña, Spain
| |
Collapse
|
458
|
Bhatt J, Mukherjee A, Shinto A, Koramadai Karuppusamy K, Korde A, Kumar M, Sarma HD, Repaka K, Dash A. Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent. Nucl Med Biol 2018; 62-63:47-53. [PMID: 29883883 DOI: 10.1016/j.nucmedbio.2018.04.003] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2018] [Revised: 03/23/2018] [Accepted: 04/27/2018] [Indexed: 10/17/2022]
Abstract
INTRODUCTION Gallium-68 based infection imaging agents are in demand to detect infection foci with high spatial resolution and sensitivity. In this study, Ubiquicidin derived octapeptide, UBI (31-38) conjugated with macrocyclic chelator NOTA was radiolabeled with 68Ga to develop infection imaging agent. METHODS Circular dichroism (CD) spectroscopy was performed to study conformational changes in UBI (31-38) and its NOTA conjugate in a "membrane like environment". Radiolabeling of NOTA-UBI (31-38) with 68Ga was optimized and quality control analysis was done by chromatography techniques. In vitro evaluation of 68Ga-NOTA-UBI (31-38) in S. aureus and preliminary biological evaluation in animal model of infection was studied. Initial clinical evaluation in three patients with suspected infection was carried out. RESULTS 68Ga-NOTA-UBI (31-38) was prepared in high radiochemical yields and high radiochemical purity. In vitro evaluation of 68Ga-NOTA-UBI (31-38) complex in S. aureus confirmed specificity of the agent for bacteria. Biodistribution studies with 68Ga-NOTA-UBI (31-38) revealed specific uptake of the complex in infected muscle compared to inflamed muscle with T/NT ratio of 3.24 ± 0.7 at 1 h post-injection. Initial clinical evaluation in two patients with histopathologically confirmed infective foci conducted after intravenous injection of 130-185 MBq of 68Ga-NOTA-UBI (31-38) and imaging at 45-60 min post-injection revealed specific uptake at the sites of infection and clearance from vital organs. No uptake of tracer was observed in suspected infection foci in one patient, which was proven to be aseptic and served as negative control. CONCLUSION This is the first report on 68Ga labeled NOTA-UBI (31-38) fragment for prospective infection imaging.
Collapse
Affiliation(s)
- Jyotsna Bhatt
- Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai 400085, India; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, India
| | - Archana Mukherjee
- Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai 400085, India; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, India.
| | - Ajit Shinto
- Dept of Nuclear Medicine and PET-CT, Kovai Medical Center and Hospital Limited, Coimbatore, India
| | | | - Aruna Korde
- Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai 400085, India; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, India; Quality control, Board of Radiation and Isotope Technology, Vashi, Navi Mumbai, India
| | - Mukesh Kumar
- Radiation Biology & Health Sciences Division, Bhabha Atomic Research Centre (BARC), Mumbai 400085, India; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, India
| | - Haladhar Dev Sarma
- Radiation Biology & Health Sciences Division, Bhabha Atomic Research Centre (BARC), Mumbai 400085, India
| | - Krishnamohan Repaka
- Quality control, Board of Radiation and Isotope Technology, Vashi, Navi Mumbai, India
| | - Ashutosh Dash
- Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai 400085, India; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, India
| |
Collapse
|
459
|
Joshi T, Kubeil M, Nsubuga A, Singh G, Gasser G, Stephan H. Harnessing the Coordination Chemistry of 1,4,7-Triazacyclononane for Biomimicry and Radiopharmaceutical Applications. Chempluschem 2018; 83:554-564. [DOI: 10.1002/cplu.201800103] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2018] [Indexed: 12/16/2022]
Affiliation(s)
- Tanmaya Joshi
- Institute of Radiopharmaceutical Cancer Research; Helmholtz-Zentrum Dresden-Rossendorf; Bautzner Landstrasse 400 01328 Dresden Germany
| | - Manja Kubeil
- Institute of Radiopharmaceutical Cancer Research; Helmholtz-Zentrum Dresden-Rossendorf; Bautzner Landstrasse 400 01328 Dresden Germany
| | - Anne Nsubuga
- Institute of Radiopharmaceutical Cancer Research; Helmholtz-Zentrum Dresden-Rossendorf; Bautzner Landstrasse 400 01328 Dresden Germany
| | - Garima Singh
- Institute of Radiopharmaceutical Cancer Research; Helmholtz-Zentrum Dresden-Rossendorf; Bautzner Landstrasse 400 01328 Dresden Germany
| | - Gilles Gasser
- Chimie ParisTech; PSL University; Laboratory for Inorganic Chemical Biology; 75005 Paris France
| | - Holger Stephan
- Institute of Radiopharmaceutical Cancer Research; Helmholtz-Zentrum Dresden-Rossendorf; Bautzner Landstrasse 400 01328 Dresden Germany
| |
Collapse
|
460
|
Egorova B, Matazova E, Mitrofanov A, Aleshin G, Trigub A, Zubenko A, Fedorova O, Fedorov Y, Kalmykov S. Novel pyridine-containing azacrownethers for the chelation of therapeutic bismuth radioisotopes: Complexation study, radiolabeling, serum stability and biodistribution. Nucl Med Biol 2018; 60:1-10. [DOI: 10.1016/j.nucmedbio.2018.01.005] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2017] [Revised: 01/01/2018] [Accepted: 01/31/2018] [Indexed: 10/18/2022]
|
461
|
Fiedler L, Kellner M, Gosewisch A, Oos R, Böning G, Lindner S, Albert N, Bartenstein P, Reulen HJ, Zeidler R, Gildehaus F. Evaluation of 177Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII. Nucl Med Biol 2018; 60:55-62. [DOI: 10.1016/j.nucmedbio.2018.02.004] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2017] [Revised: 02/05/2018] [Accepted: 02/18/2018] [Indexed: 01/15/2023]
|
462
|
Kersemans K, De Man K, Courtyn J, Van Royen T, Piron S, Moerman L, Brans B, De Vos F. Automated radiosynthesis of Al[ 18 F]PSMA-11 for large scale routine use. Appl Radiat Isot 2018; 135:19-27. [DOI: 10.1016/j.apradiso.2018.01.006] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2017] [Revised: 12/15/2017] [Accepted: 01/09/2018] [Indexed: 01/19/2023]
|
463
|
Comba P, Starke M, Wadepohl H. Optimization of Hexadentate Bispidine Ligands as Chelators for 64
CuII
PET Imaging. Chempluschem 2018; 83:597-604. [DOI: 10.1002/cplu.201800110] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2018] [Revised: 03/29/2018] [Indexed: 11/06/2022]
Affiliation(s)
- Peter Comba
- Universität Heidelberg; Anorganisch-Chemisches Institut; and Interdisciplinary Center for Scientific Computing INF 270; 69120 Heidelberg Germany
| | - Miriam Starke
- Universität Heidelberg; Anorganisch-Chemisches Institut; and Interdisciplinary Center for Scientific Computing INF 270; 69120 Heidelberg Germany
| | - Hubert Wadepohl
- Universität Heidelberg; Anorganisch-Chemisches Institut; and Interdisciplinary Center for Scientific Computing INF 270; 69120 Heidelberg Germany
| |
Collapse
|
464
|
Enel M, Leygue N, Saffon N, Galaup C, Picard C. Facile Access to the 12-Membered Macrocyclic Ligand PCTA and Its Derivatives with Carboxylate, Amide, and Phosphinate Ligating Functionalities. European J Org Chem 2018. [DOI: 10.1002/ejoc.201800066] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
- Morgane Enel
- CNRS; Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (SPCMIB); UMR-5068; 118 Route de Narbonne 31062 Toulouse cedex 9 France
- Université de Toulouse; UPS; Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (SPCMIB); 118 route de Narbonne 31062 Toulouse cedex 9 France
| | - Nadine Leygue
- CNRS; Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (SPCMIB); UMR-5068; 118 Route de Narbonne 31062 Toulouse cedex 9 France
- Université de Toulouse; UPS; Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (SPCMIB); 118 route de Narbonne 31062 Toulouse cedex 9 France
| | - Nathalie Saffon
- Institut de Chimie de Toulouse (FR 2599); 118 Route de Narbonne 31062 Toulouse cedex 9 France
| | - Chantal Galaup
- CNRS; Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (SPCMIB); UMR-5068; 118 Route de Narbonne 31062 Toulouse cedex 9 France
- Université de Toulouse; UPS; Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (SPCMIB); 118 route de Narbonne 31062 Toulouse cedex 9 France
| | - Claude Picard
- CNRS; Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (SPCMIB); UMR-5068; 118 Route de Narbonne 31062 Toulouse cedex 9 France
- Université de Toulouse; UPS; Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (SPCMIB); 118 route de Narbonne 31062 Toulouse cedex 9 France
| |
Collapse
|
465
|
Uehara T, Yokoyama M, Suzuki H, Hanaoka H, Arano Y. A Gallium-67/68–Labeled Antibody Fragment for Immuno-SPECT/PET Shows Low Renal Radioactivity Without Loss of Tumor Uptake. Clin Cancer Res 2018; 24:3309-3316. [DOI: 10.1158/1078-0432.ccr-18-0123] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2018] [Revised: 03/05/2018] [Accepted: 04/10/2018] [Indexed: 11/16/2022]
|
466
|
Huang Y, Liu Y, Liu S, Wu R, Wu Z. An Efficient Synthesis of N
,N
,N
-Substituted 1,4,7-Triazacyclononane. European J Org Chem 2018. [DOI: 10.1002/ejoc.201800048] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Yong Huang
- Brain Institute for Brain Disorders; Capital Medical University; 100069 Beijing China
| | - Yajing Liu
- School of Pharmaceutical Science; Capital Medical University; 100069 Beijing China
| | - Song Liu
- Brain Institute for Brain Disorders; Capital Medical University; 100069 Beijing China
| | - Renbo Wu
- Brain Institute for Brain Disorders; Capital Medical University; 100069 Beijing China
| | - Zehui Wu
- Brain Institute for Brain Disorders; Capital Medical University; 100069 Beijing China
| |
Collapse
|
467
|
Oliveira BL, Guo Z, Bernardes GJL. Inverse electron demand Diels-Alder reactions in chemical biology. Chem Soc Rev 2018; 46:4895-4950. [PMID: 28660957 DOI: 10.1039/c7cs00184c] [Citation(s) in RCA: 644] [Impact Index Per Article: 107.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The emerging inverse electron demand Diels-Alder (IEDDA) reaction stands out from other bioorthogonal reactions by virtue of its unmatchable kinetics, excellent orthogonality and biocompatibility. With the recent discovery of novel dienophiles and optimal tetrazine coupling partners, attention has now been turned to the use of IEDDA approaches in basic biology, imaging and therapeutics. Here we review this bioorthogonal reaction and its promising applications for live cell and animal studies. We first discuss the key factors that contribute to the fast IEDDA kinetics and describe the most recent advances in the synthesis of tetrazine and dienophile coupling partners. Both coupling partners have been incorporated into proteins for tracking and imaging by use of fluorogenic tetrazines that become strongly fluorescent upon reaction. Selected notable examples of such applications are presented. The exceptional fast kinetics of this catalyst-free reaction, even using low concentrations of coupling partners, make it amenable for in vivo radiolabelling using pretargeting methodologies, which are also discussed. Finally, IEDDA reactions have recently found use in bioorthogonal decaging to activate proteins or drugs in gain-of-function strategies. We conclude by showing applications of the IEDDA reaction in the construction of biomaterials that are used for drug delivery and multimodal imaging, among others. The use and utility of the IEDDA reaction is interdisciplinary and promises to revolutionize chemical biology, radiochemistry and materials science.
Collapse
Affiliation(s)
- B L Oliveira
- Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.
| | - Z Guo
- Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.
| | - G J L Bernardes
- Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK. and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal.
| |
Collapse
|
468
|
Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1. J Nucl Med 2018; 59:878-884. [PMID: 29545378 DOI: 10.2967/jnumed.116.186338] [Citation(s) in RCA: 115] [Impact Index Per Article: 19.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2017] [Accepted: 02/03/2018] [Indexed: 12/11/2022] Open
Abstract
With a short particle range and high linear energy transfer, α-emitting radionuclides demonstrate high cell-killing efficiencies. Even with the existence of numerous radionuclides that decay by α-particle emission, only a few of these can reasonably be exploited for therapeutic purposes. Factors including radioisotope availability and physical characteristics (e.g., half-life) can limit their widespread dissemination. The first part of this review will explore the diversity, basic radiochemistry, restrictions, and hurdles of α-emitters.
Collapse
Affiliation(s)
- Sophie Poty
- Department of Radiology and Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Lynn C Francesconi
- Department of Chemistry, Hunter College, New York, New York.,Graduate Center of City University of New York, New York, New York
| | - Michael R McDevitt
- Department of Radiology and Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York.,Department of Radiology, Weill Cornell Medical College, New York, New York
| | - Michael J Morris
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; and
| | - Jason S Lewis
- Department of Radiology and Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York .,Departments of Radiology and Pharmacology, Weill Cornell Medical College, New York, New York
| |
Collapse
|
469
|
Abstract
The interest in zirconium-89 (89Zr) as a positron-emitting radionuclide has grown considerably over the last decade due to its standardized production, long half-life of 78.2 h, favorable decay characteristics for positron emission tomography (PET) imaging and its successful use in a variety of clinical and preclinical applications. However, to be utilized effectively in PET applications it must be stably bound to a targeting ligand, and the most successfully used 89Zr chelator is desferrioxamine B (DFO), which is commercially available as the iron chelator Desferal®. Despite the prevalence of DFO in 89Zr-immuno-PET applications, the development of new ligands for this radiometal is an active area of research. This review focuses on recent advances in zirconium-89 chelation chemistry and will highlight the rapidly expanding ligand classes that are under investigation as DFO alternatives.
Collapse
Affiliation(s)
- Nikunj B Bhatt
- Department of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, NC 27157, USA.
| | - Darpan N Pandya
- Department of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, NC 27157, USA.
| | - Thaddeus J Wadas
- Department of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, NC 27157, USA.
| |
Collapse
|
470
|
Beckford Vera DR, Smith CC, Bixby LM, Glatt DM, Dunn SS, Saito R, Kim WY, Serody JS, Vincent BG, Parrott MC. Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors. PLoS One 2018; 13:e0193832. [PMID: 29513764 PMCID: PMC5841805 DOI: 10.1371/journal.pone.0193832] [Citation(s) in RCA: 64] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2017] [Accepted: 02/20/2018] [Indexed: 02/06/2023] Open
Abstract
The ability to non-invasively monitor tumor-infiltrating T cells in vivo could provide a powerful tool to visualize and quantify tumor immune infiltrates. For non-invasive evaluations in vivo, an anti-CD3 mAb was modified with desferrioxamine (DFO) and radiolabeled with zirconium-89 (Zr-89 or 89Zr). Radiolabeled 89Zr-DFO-anti-CD3 was tested for T cell detection using positron emission tomography (PET) in both healthy mice and mice bearing syngeneic bladder cancer BBN975. In vivo PET/CT and ex vivo biodistribution demonstrated preferential accumulation and visualization of tracer in the spleen, thymus, lymph nodes, and bone marrow. In tumor bearing mice, 89Zr-DFO-anti-CD3 demonstrated an 11.5-fold increase in tumor-to-blood signal compared to isotype control. Immunological profiling demonstrated no significant change to total T cell count, but observed CD4+ T cell depletion and CD8+ T cell expansion to the central and effector memory. This was very encouraging since a high CD8+ to CD4+ T cell ratio has already been associated with better patient prognosis. Ultimately, this anti-CD3 mAb allowed for in vivo imaging of homeostatic T cell distribution, and more specifically tumor-infiltrating T cells. Future applications of this radiolabeled mAb against CD3 could include prediction and monitoring of patient response to immunotherapy.
Collapse
Affiliation(s)
- Denis R. Beckford Vera
- Department of Radiology and Biomedical Research Imaging Center University of North Carolina at Chapel Hill, Marsico Hall, Chapel Hill, NC, United States of America
| | - Christof C. Smith
- Department of Microbiology and Immunology, UNC School of Medicine, Marsico Hall, Chapel Hill, NC, United States of America
| | - Lisa M. Bixby
- Division of Hematology/Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Marsico Hall, Chapel Hill, NC, United States of America
| | - Dylan M. Glatt
- Division of Molecular Pharmaceutics, Department of Pharmaceutical Sciences, UNC Eshelman School of Pharmacy, Marsico Hall, Chapel Hill, NC, United States of America
| | - Stuart S. Dunn
- Department of Radiology and Biomedical Research Imaging Center University of North Carolina at Chapel Hill, Marsico Hall, Chapel Hill, NC, United States of America
| | - Ryoichi Saito
- Division of Hematology/Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Marsico Hall, Chapel Hill, NC, United States of America
| | - William Y. Kim
- Division of Hematology/Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Marsico Hall, Chapel Hill, NC, United States of America
- Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Genetic Medicine Building, Chapel Hill, NC, United States of America
- Department of Urology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America
| | - Jonathan S. Serody
- Department of Microbiology and Immunology, UNC School of Medicine, Marsico Hall, Chapel Hill, NC, United States of America
- Division of Hematology/Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Marsico Hall, Chapel Hill, NC, United States of America
| | - Benjamin G. Vincent
- Division of Hematology/Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Marsico Hall, Chapel Hill, NC, United States of America
| | - Matthew C. Parrott
- Department of Radiology and Biomedical Research Imaging Center University of North Carolina at Chapel Hill, Marsico Hall, Chapel Hill, NC, United States of America
| |
Collapse
|
471
|
Kubíček V, Böhmová Z, Ševčíková R, Vaněk J, Lubal P, Poláková Z, Michalicová R, Kotek J, Hermann P. NOTA Complexes with Copper(II) and Divalent Metal Ions: Kinetic and Thermodynamic Studies. Inorg Chem 2018; 57:3061-3072. [PMID: 29488748 DOI: 10.1021/acs.inorgchem.7b02929] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
H3nota derivatives are among the most studied macrocyclic ligands and are widely used for metal ion binding in biology and medicine. Despite more than 40 years of chemical research on H3nota, the comprehensive study of its solution chemistry has been overlooked. Thus, the coordination behavior of H3nota with several divalent metal ions was studied in detail with respect to its application as a chelator for copper radioisotopes in medical imaging and therapy. In the solid-state structure of the free ligand in zwitterionic form, one proton is bound in the macrocyclic cavity through a strong intramolecular hydrogen-bond system supporting the high basicity of the ring amine groups (log Ka = 13.17). The high stability of the [Cu(nota)]- complex (log KML = 23.33) results in quantitative complex formation, even at pH <1.5. The ligand is moderately selective for Cu(II) over other metal ions (e.g., log KML(Zn) = 22.32 and log KML(Ni) = 19.24). This ligand forms a more stable complex with Mg(II) than with Ca(II) and forms surprisingly stable complexes with alkali-metal ions (stability order Li(I) > Na(I) > K(I)). Thus, H3nota shows high selectivity for small metal ions. The [Cu(nota)]- complex is hexacoordinated at neutral pH, and the equatorial N2O2 interaction is strengthened by complex protonation. Detailed kinetic studies showed that the Cu(II) complex is formed quickly (millisecond time scale at cCu ≈ 0.1 mM) through an out-of-cage intermediate. Conversely, conductivity measurements revealed that the Zn(II) complex is formed much more slowly than the Cu(II) complex. The Cu(II) complex has medium kinetic inertness (τ1/2 46 s; pH 0, 25 °C) and is less resistant to acid-assisted decomplexation than Cu(II) complexes with H4dota and H4teta. Surprisingly, [Cu(nota)]- decomplexation is decelerated in the presence of Zn(II) ions due to the formation of a stable dinuclear complex. In conclusion, H3nota is a good carrier of copper radionuclides because the [Cu(nota)]- complex is predominantly formed over complexes with common impurities in radiochemical formulations, Zn(II) and Ni(II), for thermodynamic and, primarily, for kinetic reasons. Furthermore, the in vivo stability of the [Cu(nota)]- complex may be increased due to the formation of dinuclear complexes when it interacts with biometals.
Collapse
Affiliation(s)
- Vojtěch Kubíček
- Department of Inorganic Chemistry, Faculty of Science , Charles University , Hlavova 8 , 128 40 Prague 2 , Czech Republic
| | - Zuzana Böhmová
- Department of Inorganic Chemistry, Faculty of Science , Charles University , Hlavova 8 , 128 40 Prague 2 , Czech Republic
| | - Romana Ševčíková
- Department of Chemistry , Masaryk University , Kotlářská 2 , 611 37 Brno , Czech Republic
| | - Jakub Vaněk
- Department of Chemistry , Masaryk University , Kotlářská 2 , 611 37 Brno , Czech Republic.,Central European Institute of Technology (CEITEC) , Masaryk University , Kamenice 5 , 625 00 Brno , Czech Republic
| | - Přemysl Lubal
- Department of Chemistry , Masaryk University , Kotlářská 2 , 611 37 Brno , Czech Republic.,Central European Institute of Technology (CEITEC) , Masaryk University , Kamenice 5 , 625 00 Brno , Czech Republic
| | - Zuzana Poláková
- Department of Inorganic Chemistry, Faculty of Science , Charles University , Hlavova 8 , 128 40 Prague 2 , Czech Republic
| | - Romana Michalicová
- Department of Chemistry , Masaryk University , Kotlářská 2 , 611 37 Brno , Czech Republic
| | - Jan Kotek
- Department of Inorganic Chemistry, Faculty of Science , Charles University , Hlavova 8 , 128 40 Prague 2 , Czech Republic
| | - Petr Hermann
- Department of Inorganic Chemistry, Faculty of Science , Charles University , Hlavova 8 , 128 40 Prague 2 , Czech Republic
| |
Collapse
|
472
|
Dai L, Jones CM, Chan WTK, Pham TA, Ling X, Gale EM, Rotile NJ, Tai WCS, Anderson CJ, Caravan P, Law GL. Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications. Nat Commun 2018; 9:857. [PMID: 29487362 PMCID: PMC5829242 DOI: 10.1038/s41467-018-03315-8] [Citation(s) in RCA: 50] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2017] [Accepted: 02/02/2018] [Indexed: 11/28/2022] Open
Abstract
Despite established clinical utilisation, there is an increasing need for safer, more inert gadolinium-based contrast agents, and for chelators that react rapidly with radiometals. Here we report the syntheses of a series of chiral DOTA chelators and their corresponding metal complexes and reveal properties that transcend the parent DOTA compound. We incorporated symmetrical chiral substituents around the tetraaza ring, imparting enhanced rigidity to the DOTA cavity, enabling control over the range of stereoisomers of the lanthanide complexes. The Gd chiral DOTA complexes are shown to be orders of magnitude more inert to Gd release than [GdDOTA]−. These compounds also exhibit very-fast water exchange rates in an optimal range for high field imaging. Radiolabeling studies with (Cu-64/Lu-177) also demonstrate faster labelling properties. These chiral DOTA chelators are alternative general platforms for the development of stable, high relaxivity contrast agents, and for radiometal complexes used for imaging and/or therapy. MRI contrast agents containing the rare earth metal gadolinium are very effective, yet unstable and thus potentially hazardous. Here, the authors developed complexes between gadolinium and the scaffolding compound DOTA with increased stability, which also lend themselves to radiometal labelling.
Collapse
Affiliation(s)
- Lixiong Dai
- Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Hong Kong SAR, China
| | - Chloe M Jones
- The Athinoula A. Martinos Center for Biomedical Imaging, The Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, 02129, United States
| | - Wesley Ting Kwok Chan
- Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Hong Kong SAR, China
| | - Tiffany A Pham
- Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States
| | - Xiaoxi Ling
- Department of Medicine, University of Pittsburgh, Pittsburgh, 15261, Pennsylvania, United States
| | - Eric M Gale
- The Athinoula A. Martinos Center for Biomedical Imaging, The Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, 02129, United States
| | - Nicholas J Rotile
- The Athinoula A. Martinos Center for Biomedical Imaging, The Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, 02129, United States
| | - William Chi-Shing Tai
- Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Hong Kong SAR, China
| | - Carolyn J Anderson
- Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States. .,Department of Medicine, University of Pittsburgh, Pittsburgh, 15261, Pennsylvania, United States. .,Departments of Pharmacology & Chemical Biology and Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States.
| | - Peter Caravan
- The Athinoula A. Martinos Center for Biomedical Imaging, The Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, 02129, United States.
| | - Ga-Lai Law
- Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Hong Kong SAR, China.
| |
Collapse
|
473
|
Liolios C, Buchmuller B, Bauder-Wüst U, Schäfer M, Leotta K, Haberkorn U, Eder M, Kopka K. Monomeric and Dimeric 68Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs). J Med Chem 2018; 61:2062-2074. [PMID: 29432691 DOI: 10.1021/acs.jmedchem.7b01856] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
The GRPr, highly expressed in prostate PCa and breast cancer BCa, is a promising target for the development of new PET radiotracers. The chelator HBED-CC ( N, N'-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine- N, N'-diacetic acid) was coupled to the bombesin peptides: HBED-C-BN(2-14) 1, HBED-CC-PEG2-[d-Tyr6,β-Ala11,Thi13,Nle14]-BN(6-14) 2, HBED-CC-Y-[d-Phe6,Sta13,Leu14]-BN(6-14) (Y = 4-amino-1-carboxymethylpiperidine) 3, and HBED-CC-{PEG2-Y-[d-Phe6,Sta13,Leu14]-BN(6-14)}2 4 (homodimer). Compounds 1-4 presented high binding affinities for GRPr (T47D, 0.56-3.51 nM; PC-3, 2.12-4.68 nM). In PC-3 and T47D cells, agonists [68Ga]1 and [68Ga]2 were mainly internalized while antagonists [68Ga]3 and [68Ga]4 were surface bound. Cell-related radioactivity reached a maximum after 45 min, while tracer levels followed GRPr expression (PC-3 > T47D > LNCaP > MDA-MB-231). [68Ga]4 showed the highest cell-bound radioactivity (PC-3 and T47D). In vivo, tumor (PC-3) targeting for [68Ga]3 and [68Ga]4 increased over time, with dynamic μPET showing clearer tumors images at later time points. [68Ga]3 and [68Ga]4 can be considered suitable PET tracers for imaging PCa and BCa expressing GRPr.
Collapse
Affiliation(s)
| | | | | | | | | | - Uwe Haberkorn
- Department of Nuclear Medicine , University of Heidelberg , Im Neuenheimer Feld 400 , 69120 Heidelberg , Germany
| | - Matthias Eder
- Division of Radiopharmaceutical Development, German Cancer Consortium (DKTK) Freiburg, and Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Hugstetter Straße 55 , 79106 Freiburg , Germany
| | | |
Collapse
|
474
|
Gopalakrishna A, Suryanarayana SV, Naik H, Dixit TS, Nayak BK, Kumar A, Maletha P, Thakur K, Deshpande A, Krishnan R, Kamaldeep, Banerjee S, Saxena A. Production, separation and supply prospects of 67Cu with the development of fast neutron sources and photonuclear technology. RADIOCHIM ACTA 2018. [DOI: 10.1515/ract-2017-2847] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Abstract
Experimental investigations have been carried out on the production of a promising therapeutic radionuclide 67Cu via the 67Zn(n,p)67Cu, 68Zn(n,x)67Cu, and 68Zn(γ,p)67Cu reaction routes. Natural zinc metal foils were irradiated with 14.1 MeV neutrons and bremsstrahlung of end-point energy 15 MeV. Radioactivity levels of 67Cu and other radioisotopes co-produced were determined by the quantification of photo-peaks by off-line γ-ray spectrometry. No carrier added 67Cu was separated from the irradiated zinc by solvent extraction. Yields >90% and high levels of radionuclidic purity were achieved. These studies indicate that the growth and development of intense fast neutron sources and photonuclear technology, will possibly aid in the sustained supply of 67Cu.
Collapse
Affiliation(s)
- Arjun Gopalakrishna
- Medical Cyclotron Facility, Board of Radiation and Isotope Technology , Mumbai 400012 , India
- Physical and Mathematical Sciences, Homi Bhabha National Institute , Mumbai 400094 , India
| | | | - Haladhara Naik
- Radiochemistry Division, Bhabha Atomic Research Centre , Mumbai 400085 , India
| | - Tanuja Sushant Dixit
- Society for Applied Microwave Electronics Engineering and Research, IIT Campus , Mumbai 400076 , India
| | - Basant Kumar Nayak
- Nuclear Physics Division, Bhabha Atomic Research Centre , Mumbai 400085 , India
| | - Amit Kumar
- Medical Cyclotron Facility, Board of Radiation and Isotope Technology , Mumbai 400012 , India
| | - Pravind Maletha
- Radiation Medicine Centre, Bhabha Atomic Research Centre , Mumbai 400 012 , India
| | - Kiran Thakur
- Society for Applied Microwave Electronics Engineering and Research, IIT Campus , Mumbai 400076 , India
| | - Abhay Deshpande
- Society for Applied Microwave Electronics Engineering and Research, IIT Campus , Mumbai 400076 , India
| | - Ramamoorthy Krishnan
- Society for Applied Microwave Electronics Engineering and Research, IIT Campus , Mumbai 400076 , India
| | - Kamaldeep
- Radiation Medicine Centre, Bhabha Atomic Research Centre , Mumbai 400 012 , India
| | - Sharmila Banerjee
- Radiation Medicine Centre, Bhabha Atomic Research Centre , Mumbai 400 012 , India
| | - Alok Saxena
- Nuclear Physics Division, Bhabha Atomic Research Centre , Mumbai 400085 , India
| |
Collapse
|
475
|
Zhang KY, Yu Q, Wei H, Liu S, Zhao Q, Huang W. Long-Lived Emissive Probes for Time-Resolved Photoluminescence Bioimaging and Biosensing. Chem Rev 2018; 118:1770-1839. [DOI: 10.1021/acs.chemrev.7b00425] [Citation(s) in RCA: 479] [Impact Index Per Article: 79.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Kenneth Yin Zhang
- Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing 210023, P. R. China
| | - Qi Yu
- Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing 210023, P. R. China
| | - Huanjie Wei
- Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing 210023, P. R. China
| | - Shujuan Liu
- Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing 210023, P. R. China
| | - Qiang Zhao
- Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing 210023, P. R. China
| | - Wei Huang
- Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing 210023, P. R. China
- Shaanxi
Institute of Flexible Electronics (SIFE), Northwestern Polytechnical University (NPU), Xi’an 710072, P. R. China
- Key
Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced
Materials (IAM), Jiangsu National Synergetic Innovation Center for
Advanced Materials (SICAM), Nanjing Tech University (NanjingTech), Nanjing 211800, P. R. China
| |
Collapse
|
476
|
Lizal F, Jedelsky J, Morgan K, Bauer K, Llop J, Cossio U, Kassinos S, Verbanck S, Ruiz-Cabello J, Santos A, Koch E, Schnabel C. Experimental methods for flow and aerosol measurements in human airways and their replicas. Eur J Pharm Sci 2018; 113:95-131. [DOI: 10.1016/j.ejps.2017.08.021] [Citation(s) in RCA: 37] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2017] [Revised: 08/14/2017] [Accepted: 08/17/2017] [Indexed: 12/29/2022]
|
477
|
Kurihara K, Ueda M, Hara I, Ozeki E, Togashi K, Kimura S. Polymeric Micelle of A₃B-Type Lactosome as a Vehicle for Targeting Meningeal Dissemination. NANOMATERIALS 2018; 8:nano8020079. [PMID: 29385027 PMCID: PMC5853711 DOI: 10.3390/nano8020079] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/30/2017] [Revised: 12/22/2017] [Accepted: 01/08/2018] [Indexed: 11/30/2022]
Abstract
Polymeric micelle of the A3B-type lactosome comprising (poly(sarcosine))3-b-poly(l-lactic acid) was labeled with 111In. The 111In-labeled A3B-type lactosome was administered to the model mice bearing meningeal dissemination and bone metastasis at mandible. With single-photon emission computed tomography (SPECT) imaging, the meningeal dissemination was identified successfully by 111In-labeled A3B-type lactosome, which was superior to 201TlCl in regard of the imaging contrast. The 111In-labeled A3B-type lactosome was also potential in imaging selectively of bone metastasis at mandible, whilst a nonspecific imaging of the whole bone was obtained by the SPECT imaging using 99mTc-HMDP. The polymeric micelle of the A3B-type lactosome was therefore found to be effective as a vehicle of 111In to be targeted to meningeal dissemination and bone metastasis.
Collapse
Affiliation(s)
- Kensuke Kurihara
- Clinical Division of Diagnostic Radiology, Kyoto University Hospital 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
| | - Motoki Ueda
- Clinical Division of Diagnostic Radiology, Kyoto University Hospital 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
| | - Isao Hara
- Technology Research Laboratory, Shimadzu Corporation, Kyoto 619-0237, Japan.
| | - Eiichi Ozeki
- Technology Research Laboratory, Shimadzu Corporation, Kyoto 619-0237, Japan.
| | - Kaori Togashi
- Clinical Division of Diagnostic Radiology, Kyoto University Hospital 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
| | - Shunsaku Kimura
- Department of Material Chemistry, Graduate School of Engineering, Kyoto University Kyoto-Daigaku-Katsura, Nishikyo-ku, Kyoto 615-8510, Japan.
| |
Collapse
|
478
|
Codd R, Richardson-Sanchez T, Telfer TJ, Gotsbacher MP. Advances in the Chemical Biology of Desferrioxamine B. ACS Chem Biol 2018; 13:11-25. [PMID: 29182270 DOI: 10.1021/acschembio.7b00851] [Citation(s) in RCA: 47] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Desferrioxamine B (DFOB) was discovered in the late 1950s as a hydroxamic acid metabolite of the soil bacterium Streptomyces pilosus. The exquisite affinity of DFOB for Fe(III) identified its potential for removing excess iron from patients with transfusion-dependent hemoglobin disorders. Many studies have used semisynthetic chemistry to produce DFOB adducts with new properties and broad-ranging functions. More recent approaches in chemical biology have revealed some nuances of DFOB biosynthesis and discovered new DFOB-derived drugs and radiometal imaging agents. The current and potential applications of DFOB continue to inspire a rich body of chemical biology research focused on this bacterial metabolite.
Collapse
Affiliation(s)
- Rachel Codd
- School of Medical Sciences
(Pharmacology), The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Tomas Richardson-Sanchez
- School of Medical Sciences
(Pharmacology), The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Thomas J. Telfer
- School of Medical Sciences
(Pharmacology), The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Michael P. Gotsbacher
- School of Medical Sciences
(Pharmacology), The University of Sydney, Sydney, New South Wales 2006, Australia
| |
Collapse
|
479
|
Price TW, Greenman J, Stasiuk GJ. Current advances in ligand design for inorganic positron emission tomography tracers 68Ga, 64Cu, 89Zr and 44Sc. Dalton Trans 2018; 45:15702-15724. [PMID: 26865360 DOI: 10.1039/c5dt04706d] [Citation(s) in RCA: 73] [Impact Index Per Article: 12.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
A key part of the development of metal based Positron Emission Tomography probes is the chelation of the radiometal. In this review the recent developments in the chelation of four positron emitting radiometals, 68Ga, 64Cu, 89Zr and 44Sc, are explored. The factors that effect the chelation of each radio metal and the ideal ligand system will be discussed with regards to high in vivo stability, complexation conditions, conjugation to targeting motifs and complexation kinetics. A series of cyclic, cross-bridged and acyclic ligands will be discussed, such as CP256 which forms stable complexes with 68Ga under mild conditions and PCB-TE2A which has been shown to form a highly stable complex with 64Cu. 89Zr and 44Sc have seen significant development in recent years with a number of chelates being applied to each metal - eight coordinate di-macrocyclic terephthalamide ligands were found to rapidly produce more stable complexes with 89Zr than the widely used DFO.
Collapse
Affiliation(s)
- Thomas W Price
- School of Biological, Biomedical and Environmental Sciences, The University of Hull, HU6 7RX, UK. and Positron Emission Tomography Research Centre, The University of Hull, HU6 7RX, UK
| | - John Greenman
- School of Biological, Biomedical and Environmental Sciences, The University of Hull, HU6 7RX, UK.
| | - Graeme J Stasiuk
- School of Biological, Biomedical and Environmental Sciences, The University of Hull, HU6 7RX, UK. and Positron Emission Tomography Research Centre, The University of Hull, HU6 7RX, UK
| |
Collapse
|
480
|
Ševčík R, Vaněk J, Michalicová R, Lubal P, Hermann P, Santos IC, Santos I, Campello MPC. Formation and decomplexation kinetics of copper(ii) complexes with cyclen derivatives having mixed carboxylate and phosphonate pendant arms. Dalton Trans 2018; 45:12723-33. [PMID: 27460053 DOI: 10.1039/c6dt01127f] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
The kinetic properties of Cu(ii) complexes of H4dota and its analogues with one (H5do3ap), two in the 1,7-position (trans-H6do2a2p), three (H7doa3p) and four (H8dotp) phosphonic acid pendant arms were investigated. The formation of a Cu(ii) complex with H4dota, trans-H6do2a2p and H8dotp at a slightly acidic pH is faster for the phosphonic acid derivatives than for H4dota, but with no simple dependence on the number of -CH2PO3H2 substituents (trans-H6do2a2p > H8dotp > H4dota; pH 4-6). Relative differences in the reactivity among the differently protonated species (HnL(x-)) of the same ligand are successively decreased with the more phosphonic acid groups in the ligand. The faster complexation is probably caused by the higher ability of phosphonates to bind the metal ion and/or to assist in the transfer of protons from the ring amine groups to the bulk water. The acid-assisted decomplexation kinetics of the complexes was followed in highly acidic solutions ([H(+)] = 0.01-5 M) and at different temperatures (15-70 °C) to determine the activation parameters of the reaction. The kinetic inertness of the Cu(ii) complexes follows the order: H4dota > H5do3ap > trans-H6do2a2p > H7doa3p > H8dotp. To obtain information on the influence of additional pendant arms, analogous data were obtained for trans-H2do2a. The ligand is less reactive than H4dota, but the kinetic inertness of its Cu(ii) complex is similar to that of the H4dota complex. As it was considered that the published thermodynamics data on the Cu(ii)-H8dotp system are probably incorrect, the system was re-investigated. It showed a very high stability for the [Cu(dotp)](6-) species and the easy formation of several Cu2L species in the presence of an excess of the metal ion. Also, the structure of the (H6doa3p)(-) anion in the solid state was determined. These experimental data demonstrate that the substitution of acetic acid pendant arms by methylphosphonic acid ones in H4dota-like ligands increases the rate of complexation but significantly decreases the kinetic inertness of the Cu(ii) complexes.
Collapse
Affiliation(s)
- R Ševčík
- Department of Chemistry, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic.
| | - J Vaněk
- Department of Chemistry, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic. and Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
| | - R Michalicová
- Department of Chemistry, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic.
| | - P Lubal
- Department of Chemistry, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic. and Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic
| | - P Hermann
- Department of Inorganic Chemistry, Faculty of Science, Universita Karlova (Charles University), Hlavova 2030, 128 40 Prague 2, Czech Republic
| | - I C Santos
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal.
| | - I Santos
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal.
| | - M P C Campello
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal.
| |
Collapse
|
481
|
Procházková S, Kubíček V, Kotek J, Vágner A, Notni J, Hermann P. Lanthanide(iii) complexes of monophosphinate/monophosphonate DOTA-analogues: effects of the substituents on the formation rate and radiolabelling yield. Dalton Trans 2018; 47:13006-13015. [DOI: 10.1039/c8dt02608d] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Highly acidic additional coordinating groups in the pendant arms increase the radiolabelling yield of DOTA-like complexes.
Collapse
Affiliation(s)
- Soňa Procházková
- Department of Inorganic Chemistry
- Faculty of Science
- Charles University
- Czech Republic
| | - Vojtěch Kubíček
- Department of Inorganic Chemistry
- Faculty of Science
- Charles University
- Czech Republic
| | - Jan Kotek
- Department of Inorganic Chemistry
- Faculty of Science
- Charles University
- Czech Republic
| | - Adrienn Vágner
- Department of Inorganic and Analytical Chemistry
- University of Debrecen
- Debrecen
- Hungary
| | - Johannes Notni
- Lehrstuhl für Pharmazeutische Radiochemie
- Technische Universität München
- D-85748 Garching
- Germany
| | - Petr Hermann
- Department of Inorganic Chemistry
- Faculty of Science
- Charles University
- Czech Republic
| |
Collapse
|
482
|
Abstract
Radiometal based radiopharmaceuticals for imaging and therapy require selective ligands (bifunctional chelators, BFCs) that form metal complexes, which are inert against trans-chelation under physiological conditions, linked to a biological vector, directing them to the targeted tissue. Bispidine ligands with a very rigid backbone and widely variable donor sets are reviewed as an ideal class of BFCs, and recent applications are discussed.
Collapse
Affiliation(s)
- Peter Comba
- Ruprecht-Karls Universität Heidelberg
- Anorganisch-Chemisches Institut and Interdisciplinary Center for Scientific Computing (IWR)
- 69120 Heidelberg
- Germany
| | - Marion Kerscher
- Ruprecht-Karls Universität Heidelberg
- Anorganisch-Chemisches Institut and Interdisciplinary Center for Scientific Computing (IWR)
- 69120 Heidelberg
- Germany
| | - Katharina Rück
- Ruprecht-Karls Universität Heidelberg
- Anorganisch-Chemisches Institut and Interdisciplinary Center for Scientific Computing (IWR)
- 69120 Heidelberg
- Germany
| | - Miriam Starke
- Ruprecht-Karls Universität Heidelberg
- Anorganisch-Chemisches Institut and Interdisciplinary Center for Scientific Computing (IWR)
- 69120 Heidelberg
- Germany
| |
Collapse
|
483
|
Pujales-Paradela R, Rodríguez-Rodríguez A, Gayoso-Padula A, Brandariz I, Valencia L, Esteban-Gómez D, Platas-Iglesias C. On the consequences of the stereochemical activity of the Bi(iii) 6s2 lone pair in cyclen-based complexes. The [Bi(DO3A)] case. Dalton Trans 2018; 47:13830-13842. [DOI: 10.1039/c8dt02602e] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The spatial arrangement of donor atoms in Bi(iii) cyclen derivatives modulates the orientation and activity of the 6s2 lone pair.
Collapse
Affiliation(s)
- Rosa Pujales-Paradela
- Universidade da Coruña
- Centro de Investigacións Científicas Avanzadas (CICA) and Departamento de Química
- Facultade de Ciencias
- A Coruña
- Spain
| | - Aurora Rodríguez-Rodríguez
- Universidade da Coruña
- Centro de Investigacións Científicas Avanzadas (CICA) and Departamento de Química
- Facultade de Ciencias
- A Coruña
- Spain
| | - Antonella Gayoso-Padula
- Universidade da Coruña
- Centro de Investigacións Científicas Avanzadas (CICA) and Departamento de Química
- Facultade de Ciencias
- A Coruña
- Spain
| | - Isabel Brandariz
- Universidade da Coruña
- Centro de Investigacións Científicas Avanzadas (CICA) and Departamento de Química
- Facultade de Ciencias
- A Coruña
- Spain
| | - Laura Valencia
- Departamento de Química Inorgánica
- Facultad de Ciencias
- Universidade de Vigo
- 36310 Pontevedra
- Spain
| | - David Esteban-Gómez
- Universidade da Coruña
- Centro de Investigacións Científicas Avanzadas (CICA) and Departamento de Química
- Facultade de Ciencias
- A Coruña
- Spain
| | - Carlos Platas-Iglesias
- Universidade da Coruña
- Centro de Investigacións Científicas Avanzadas (CICA) and Departamento de Química
- Facultade de Ciencias
- A Coruña
- Spain
| |
Collapse
|
484
|
Paúrová M, David T, Císařová I, Lubal P, Hermann P, Kotek J. Optimization of the selectivity and rate of copper radioisotope complexation: formation and dissociation kinetic studies of 1,4,8-trimethylcyclam-based ligands with different coordinating pendant arms. NEW J CHEM 2018. [DOI: 10.1039/c8nj00419f] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Influence of coordinating pendant arm character on selectivity and rate of copper(ii) complexation was investigated to optimize ligands for radiomedicinal use.
Collapse
Affiliation(s)
- Monika Paúrová
- Department of Inorganic Chemistry
- Faculty of Science
- Charles University
- Czech Republic
| | - Tomáš David
- Department of Inorganic Chemistry
- Faculty of Science
- Charles University
- Czech Republic
| | - Ivana Císařová
- Department of Inorganic Chemistry
- Faculty of Science
- Charles University
- Czech Republic
| | - Přemysl Lubal
- Department of Chemistry
- Faculty of Science
- Masaryk University
- Brno
- Czech Republic
| | - Petr Hermann
- Department of Inorganic Chemistry
- Faculty of Science
- Charles University
- Czech Republic
| | - Jan Kotek
- Department of Inorganic Chemistry
- Faculty of Science
- Charles University
- Czech Republic
| |
Collapse
|
485
|
Mansour N, Paquette M, Ait-Mohand S, Dumulon-Perreault V, Guérin B. Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [ 64 Cu]-DOTHA 2 -PEG-RM26. Nucl Med Biol 2018; 56:31-38. [DOI: 10.1016/j.nucmedbio.2017.10.006] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2017] [Revised: 10/17/2017] [Accepted: 10/18/2017] [Indexed: 02/08/2023]
|
486
|
McInnes LE, Rudd SE, Donnelly PS. Copper, gallium and zirconium positron emission tomography imaging agents: The importance of metal ion speciation. Coord Chem Rev 2017. [DOI: 10.1016/j.ccr.2017.05.011] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
487
|
Shah MA, Zhang X, Rossin R, Robillard MS, Fisher DR, Bueltmann T, Hoeben FJM, Quinn TP. Metal-Free Cycloaddition Chemistry Driven Pretargeted Radioimmunotherapy Using α-Particle Radiation. Bioconjug Chem 2017; 28:3007-3015. [DOI: 10.1021/acs.bioconjchem.7b00612] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Affiliation(s)
- Manankumar A. Shah
- Department
of Biochemistry, University of Missouri, Columbia, Missouri 65211, United States
- Harry S. Truman Veterans Administration Hospital, Columbia, Missouri 65201, United States
| | - Xiuli Zhang
- Department
of Biochemistry, University of Missouri, Columbia, Missouri 65211, United States
- Harry S. Truman Veterans Administration Hospital, Columbia, Missouri 65201, United States
| | - Raffaella Rossin
- Tagworks Pharmaceuticals, Geert
Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands
| | - Marc S. Robillard
- Tagworks Pharmaceuticals, Geert
Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands
| | - Darrell R. Fisher
- Versant Medical Physics and Radiation Safety, Richland, Washington 99354, United States
| | - Tyler Bueltmann
- Department
of Biochemistry, University of Missouri, Columbia, Missouri 65211, United States
| | | | - Thomas P. Quinn
- Department
of Biochemistry, University of Missouri, Columbia, Missouri 65211, United States
- Harry S. Truman Veterans Administration Hospital, Columbia, Missouri 65201, United States
| |
Collapse
|
488
|
Burke BP, Cawthorne C, Archibald SJ. Multimodal nanoparticle imaging agents: design and applications. PHILOSOPHICAL TRANSACTIONS. SERIES A, MATHEMATICAL, PHYSICAL, AND ENGINEERING SCIENCES 2017; 375:rsta.2017.0261. [PMID: 29038384 DOI: 10.1098/rsta.2017.0261] [Citation(s) in RCA: 46] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 09/04/2017] [Indexed: 05/24/2023]
Abstract
Molecular imaging, where the location of molecules or nanoscale constructs can be tracked in the body to report on disease or biochemical processes, is rapidly expanding to include combined modality or multimodal imaging. No single imaging technique can offer the optimum combination of properties (e.g. resolution, sensitivity, cost, availability). The rapid technological advances in hardware to scan patients, and software to process and fuse images, are pushing the boundaries of novel medical imaging approaches, and hand-in-hand with this is the requirement for advanced and specific multimodal imaging agents. These agents can be detected using a selection from radioisotope, magnetic resonance and optical imaging, among others. Nanoparticles offer great scope in this area as they lend themselves, via facile modification procedures, to act as multifunctional constructs. They have relevance as therapeutics and drug delivery agents that can be tracked by molecular imaging techniques with the particular development of applications in optically guided surgery and as radiosensitizers. There has been a huge amount of research work to produce nanoconstructs for imaging, and the parameters for successful clinical translation and validation of therapeutic applications are now becoming much better understood. It is an exciting time of progress for these agents as their potential is closer to being realized with translation into the clinic. The coming 5-10 years will be critical, as we will see if the predicted improvement in clinical outcomes becomes a reality. Some of the latest advances in combination modality agents are selected and the progression pathway to clinical trials analysed.This article is part of the themed issue 'Challenges for chemistry in molecular imaging'.
Collapse
Affiliation(s)
- Benjamin P Burke
- Department of Chemistry, Cottingham Road, Hull HU6 7RX, UK
- Positron Emission Tomography Research Centre, Cottingham Road, Hull HU6 7RX, UK
| | - Christopher Cawthorne
- Positron Emission Tomography Research Centre, Cottingham Road, Hull HU6 7RX, UK
- School of Life Sciences, University of Hull, Cottingham Road, Hull HU6 7RX, UK
| | - Stephen J Archibald
- Department of Chemistry, Cottingham Road, Hull HU6 7RX, UK
- Positron Emission Tomography Research Centre, Cottingham Road, Hull HU6 7RX, UK
| |
Collapse
|
489
|
Ding Y, Caucci L, Barrett HH. Null functions in three-dimensional imaging of alpha and beta particles. Sci Rep 2017; 7:15807. [PMID: 29150683 PMCID: PMC5693958 DOI: 10.1038/s41598-017-16111-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2017] [Accepted: 11/07/2017] [Indexed: 11/16/2022] Open
Abstract
Null functions of an imaging system are functions in the object space that give exactly zero data. Hence, they represent the intrinsic limitations of the imaging system. Null functions exist in all digital imaging systems, because these systems map continuous objects to discrete data. However, the emergence of detectors that measure continuous data, e.g. particle-processing (PP) detectors, has the potential to eliminate null functions. PP detectors process signals produced by each particle and estimate particle attributes, which include two position coordinates and three components of momentum, as continuous variables. We consider Charged-Particle Emission Tomography (CPET), which relies on data collected by a PP detector to reconstruct the 3D distribution of a radioisotope that emits alpha or beta particles, and show empirically that the null functions are significantly reduced for alpha particles if ≥3 attributes are measured or for beta particles with five attributes measured.
Collapse
Affiliation(s)
- Yijun Ding
- Department of Physics, University of Arizona, Tucson, AZ, USA.
| | - Luca Caucci
- Department of Medical Imaging, University of Arizona, Tucson, AZ, USA
| | - Harrison H Barrett
- Department of Medical Imaging, University of Arizona, Tucson, AZ, USA
- College of Optical Sciences, University of Arizona, Tucson, AZ, USA
| |
Collapse
|
490
|
Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a 68Ga-THP-scFv targeting the prostate-specific membrane antigen. EJNMMI Res 2017; 7:86. [PMID: 29067565 PMCID: PMC5655379 DOI: 10.1186/s13550-017-0336-6] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2017] [Accepted: 10/16/2017] [Indexed: 12/27/2022] Open
Abstract
Background Labelling proteins with gallium-68 using bifunctional chelators is often problematic because of unsuitably harsh labelling conditions such as low pH or high temperature and may entail post-labelling purification. To determine whether tris(hydroxypyridinone) (THP) bifunctional chelators offer a potential solution to this problem, we have evaluated the labelling and biodistribution of a THP conjugate with a new single-chain antibody against the prostate-specific membrane antigen (PSMA), an attractive target for staging prostate cancer (PCa). A single-chain variable fragment (scFv) of J591, a monoclonal antibody that recognises an external epitope of PSMA, was prepared in order to achieve biokinetics matched to the half-life of gallium-68. The scFv, J591c-scFv, was engineered with a C-terminal cysteine. Results J591c-scFv was produced in HEK293T cells and purified by size-exclusion chromatography. A maleimide THP derivative (THP-mal) was coupled site-specifically to the C-terminal cysteine residue. The THP-mal-J591c-scFv conjugate was labelled with ammonium acetate-buffered gallium-68 from a 68Ge/68Ga generator at room temperature and neutral pH. The labelled conjugate was evaluated in the PCa cell line DU145 and its PSMA-overexpressing variant in vitro and xenografted in SCID mice. J591c-scFv was produced in yields of 4–6 mg/l culture supernatant and efficiently coupled with the THP-mal bifunctional chelator. Labelling yields > 95% were achieved at room temperature following incubation of 5 μg conjugate with gallium-68 for 5 min without post-labelling purification. 68Ga-THP-mal-J591c-scFv was stable in serum and showed selective binding to the DU145-PSMA cell line, allowing an IC50 value of 31.5 nM to be determined for unmodified J591c-scFv. Serial PET/CT imaging showed rapid, specific tumour uptake and clearance via renal elimination. Accumulation in DU145-PSMA xenografts at 90 min post-injection was 5.4 ± 0.5%ID/g compared with 0.5 ± 0.2%ID/g in DU145 tumours (n = 4). Conclusions The bifunctional chelator THP-mal enabled simple, rapid, quantitative, one-step room temperature radiolabelling of a protein with gallium-68 at neutral pH without a need for post-labelling purification. The resultant gallium-68 complex shows high affinity for PSMA and favourable in vivo targeting properties in a xenograft model of PCa. Electronic supplementary material The online version of this article (10.1186/s13550-017-0336-6) contains supplementary material, which is available to authorized users.
Collapse
|
491
|
Comba P, Jermilova U, Orvig C, Patrick BO, Ramogida CF, Rück K, Schneider C, Starke M. Octadentate Picolinic Acid-Based Bispidine Ligand for Radiometal Ions. Chemistry 2017; 23:15945-15956. [DOI: 10.1002/chem.201702284] [Citation(s) in RCA: 47] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2017] [Indexed: 11/10/2022]
Affiliation(s)
- Peter Comba
- Universität Heidelberg; Anorganisch-Chemisches Institut and Interdisciplinary Center for Scientific Computing, INF 270, D-; 69120 Heidelberg Germany
| | - Una Jermilova
- Life Sciences Division; TRIUMF; 4004 Wesbrook Mall Vancouver V6T 2A3 British Columbia Canada
| | - Chris Orvig
- Medicinal Inorganic Chemistry Group; University of British Columbia; Department of Chemistry; 2036 Main Mall Vancouver V6T 1Z1 British Columbia Canada
| | - Brian O. Patrick
- Medicinal Inorganic Chemistry Group; University of British Columbia; Department of Chemistry; 2036 Main Mall Vancouver V6T 1Z1 British Columbia Canada
| | - Caterina F. Ramogida
- Life Sciences Division; TRIUMF; 4004 Wesbrook Mall Vancouver V6T 2A3 British Columbia Canada
| | - Katharina Rück
- Universität Heidelberg; Anorganisch-Chemisches Institut and Interdisciplinary Center for Scientific Computing, INF 270, D-; 69120 Heidelberg Germany
| | - Christina Schneider
- Universität Heidelberg; Anorganisch-Chemisches Institut and Interdisciplinary Center for Scientific Computing, INF 270, D-; 69120 Heidelberg Germany
| | - Miriam Starke
- Universität Heidelberg; Anorganisch-Chemisches Institut and Interdisciplinary Center for Scientific Computing, INF 270, D-; 69120 Heidelberg Germany
| |
Collapse
|
492
|
Thiele NA, Brown V, Kelly JM, Amor‐Coarasa A, Jermilova U, MacMillan SN, Nikolopoulou A, Ponnala S, Ramogida CF, Robertson AKH, Rodríguez‐Rodríguez C, Schaffer P, Williams C, Babich JW, Radchenko V, Wilson JJ. An Eighteen‐Membered Macrocyclic Ligand for Actinium‐225 Targeted Alpha Therapy. Angew Chem Int Ed Engl 2017; 56:14712-14717. [DOI: 10.1002/anie.201709532] [Citation(s) in RCA: 109] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2017] [Indexed: 01/19/2023]
Affiliation(s)
- Nikki A. Thiele
- Chemistry and Chemical Biology Cornell University Ithaca NY 14853 USA
| | - Victoria Brown
- Life Science Division, TRIUMF Vancouver BC V6T 2A3 Canada
| | | | | | - Una Jermilova
- Life Science Division, TRIUMF Vancouver BC V6T 2A3 Canada
| | | | | | | | | | | | - Cristina Rodríguez‐Rodríguez
- Fac. of Pharmaceutical Sciences, Dept. of Physics and Astronomy and Centre for Comparative Medicine University of British Columbia Vancouver BC V6T 1W5 Canada
| | - Paul Schaffer
- Life Science Division, TRIUMF Vancouver BC V6T 2A3 Canada
| | | | | | | | - Justin J. Wilson
- Chemistry and Chemical Biology Cornell University Ithaca NY 14853 USA
| |
Collapse
|
493
|
Thiele NA, Brown V, Kelly JM, Amor‐Coarasa A, Jermilova U, MacMillan SN, Nikolopoulou A, Ponnala S, Ramogida CF, Robertson AKH, Rodríguez‐Rodríguez C, Schaffer P, Williams C, Babich JW, Radchenko V, Wilson JJ. An Eighteen‐Membered Macrocyclic Ligand for Actinium‐225 Targeted Alpha Therapy. Angew Chem Int Ed Engl 2017. [DOI: 10.1002/ange.201709532] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Nikki A. Thiele
- Chemistry and Chemical Biology Cornell University Ithaca NY 14853 USA
| | - Victoria Brown
- Life Science Division, TRIUMF Vancouver BC V6T 2A3 Canada
| | | | | | - Una Jermilova
- Life Science Division, TRIUMF Vancouver BC V6T 2A3 Canada
| | | | | | | | | | | | - Cristina Rodríguez‐Rodríguez
- Fac. of Pharmaceutical Sciences, Dept. of Physics and Astronomy and Centre for Comparative Medicine University of British Columbia Vancouver BC V6T 1W5 Canada
| | - Paul Schaffer
- Life Science Division, TRIUMF Vancouver BC V6T 2A3 Canada
| | | | | | | | - Justin J. Wilson
- Chemistry and Chemical Biology Cornell University Ithaca NY 14853 USA
| |
Collapse
|
494
|
Gillet R, Roux A, Brandel J, Huclier-Markai S, Camerel F, Jeannin O, Nonat AM, Charbonnière LJ. A Bispidol Chelator with a Phosphonate Pendant Arm: Synthesis, Cu(II) Complexation, and 64Cu Labeling. Inorg Chem 2017; 56:11738-11752. [DOI: 10.1021/acs.inorgchem.7b01731] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Raphaël Gillet
- Laboratoire d’Ingénierie
Moléculaire Appliquée à l’Analyse, Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - Amandine Roux
- Laboratoire d’Ingénierie
Moléculaire Appliquée à l’Analyse, Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - Jérémy Brandel
- Laboratoire de Reconnaissance et Procédés
de Séparation Moléculaire, Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - Sandrine Huclier-Markai
- GIP Arronax, 1 rue Aronnax, CS 10112, F-44817 Saint-Herblain, France
- Subatech Laboratory, UMR 6457, Ecole des Mines de Nantes, IN2P3/CNRS, Université de Nantes, 4 rue Alfred Kastler, F-44307 Nantes, France
| | - Franck Camerel
- Laboratoire Matière Condensée et Systèmes
Électroactifs, Institut des Sciences Chimiques de Rennes, UMR-CNRS 6226, 263 Avenue du Général Leclerc, CS
74205, F-35042 Rennes Cedex, France
| | - Olivier Jeannin
- Laboratoire Matière Condensée et Systèmes
Électroactifs, Institut des Sciences Chimiques de Rennes, UMR-CNRS 6226, 263 Avenue du Général Leclerc, CS
74205, F-35042 Rennes Cedex, France
| | - Aline M. Nonat
- Laboratoire d’Ingénierie
Moléculaire Appliquée à l’Analyse, Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| | - Loïc J. Charbonnière
- Laboratoire d’Ingénierie
Moléculaire Appliquée à l’Analyse, Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France
| |
Collapse
|
495
|
Jackson IM, Scott PJ, Thompson S. Clinical Applications of Radiolabeled Peptides for PET. Semin Nucl Med 2017; 47:493-523. [DOI: 10.1053/j.semnuclmed.2017.05.007] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
496
|
Heskamp S, Raavé R, Boerman O, Rijpkema M, Goncalves V, Denat F. 89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry. Bioconjug Chem 2017; 28:2211-2223. [PMID: 28767228 PMCID: PMC5609224 DOI: 10.1021/acs.bioconjchem.7b00325] [Citation(s) in RCA: 132] [Impact Index Per Article: 18.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
![]()
Immuno-positron
emission tomography (immunoPET) with 89Zr-labeled antibodies
has shown great potential in cancer imaging.
It can provide important information about the pharmacokinetics and
tumor-targeting properties of monoclonal antibodies and may help in
anticipating on toxicity. Furthermore, it allows accurate dose planning
for individualized radioimmunotherapy and may aid in patient selection
and early-response monitoring for targeted therapies. The most commonly
used chelator for 89Zr is desferrioxamine (DFO). Preclinical
studies have shown that DFO is not an ideal chelator because the 89Zr–DFO complex is partly unstable in vivo, which results
in the release of 89Zr from the chelator and the subsequent
accumulation of 89Zr in bone. This bone accumulation interferes
with accurate interpretation and quantification of bone uptake on
PET images. Therefore, there is a need for novel chelators that allow
more stable complexation of 89Zr. In this Review, we will
describe the most recent developments in 89Zr radiochemistry,
including novel chelators and site-specific conjugation methods.
Collapse
Affiliation(s)
- Sandra Heskamp
- Department of Radiology and Nuclear Medicine, Radboud University Medical Center , Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, The Netherlands
| | - René Raavé
- Department of Radiology and Nuclear Medicine, Radboud University Medical Center , Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, The Netherlands
| | - Otto Boerman
- Department of Radiology and Nuclear Medicine, Radboud University Medical Center , Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, The Netherlands
| | - Mark Rijpkema
- Department of Radiology and Nuclear Medicine, Radboud University Medical Center , Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, The Netherlands
| | - Victor Goncalves
- Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR6302, CNRS, Université Bourgogne Franche-Comté , F-21000 Dijon, France
| | - Franck Denat
- Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR6302, CNRS, Université Bourgogne Franche-Comté , F-21000 Dijon, France
| |
Collapse
|
497
|
PET Imaging of FSHR Expression in Tumors with 68Ga-Labeled FSH1 Peptide. CONTRAST MEDIA & MOLECULAR IMAGING 2017; 2017:2674502. [PMID: 29097913 PMCID: PMC5612759 DOI: 10.1155/2017/2674502] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/29/2017] [Revised: 07/07/2017] [Accepted: 07/25/2017] [Indexed: 12/13/2022]
Abstract
FSHR is an appealing target for cancer theranostics. Radiolabeled FSH1 and its derivatives have shown potential to in vivo detect FSHR expression. However, moderate labeling yields (~50% nondecay-corrected) may partially limit their wide use. 68Ga is an excellent PET nuclide due to availability, nearly quantitative reaction, and short physical half-life. In this study, 68Ga labeled FSH1 peptide was developed for imaging of FSHR in cancers. In vitro studies and MicroPET imaging were performed in PC-3 prostate tumor model. [68Ga] Ga-NOTA-MAL-FSH1 can be produced within 20 min with 93.2 ± 2.1% yield and the radiochemical purity was greater than 95%. It showed that [68Ga] Ga-NOTA-MAL-FSH1 possessed FSHR binding affinities. The tracer was stable in PBS and human serum for at least 2 hours. MicroPET imaging revealed that the PC-3 xenografts were clearly visualized and the tumor uptakes were 1.87 ± 0.10, 1.26 ± 0.06, and 0.71 ± 0.10% ID/g at 0.5, 1 h, and 2 h postinjection. The corresponding tumor to blood and tumor to muscle ratios were 1.77 ± 0.70, 7.94 ± 1.35, and 10.37 ± 1.16 and 7.42 ± 0.46, 26.13 ± 2.99, and 36.40 ± 2.54, respectively. FSHR binding specificity was also demonstrated by reduced tumor uptake of [68Ga] Ga-NOTA-MAL-FSH1 after coinjecting excess unlabeled FSH1 peptide. The favorable characters of [68Ga] Ga-NOTA-MAL-FSH1 such as convenient synthesis and specific tumor uptake warrant its further investigation for FSHR expression imaging.
Collapse
|
498
|
Weekes DM, Jaraquemada-Peláez MDG, Kostelnik TI, Patrick BO, Orvig C. Di- and Trivalent Metal-Ion Solution Studies with the Phosphinate-Containing Heterocycle DEDA-(PO). Inorg Chem 2017; 56:10155-10161. [DOI: 10.1021/acs.inorgchem.7b01117] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- David M. Weekes
- Medicinal Inorganic Chemistry Group, Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada
| | - Maria de Guadalupe Jaraquemada-Peláez
- Medicinal Inorganic Chemistry Group, Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada
| | - Thomas I. Kostelnik
- Medicinal Inorganic Chemistry Group, Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada
| | - Brian O. Patrick
- Medicinal Inorganic Chemistry Group, Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada
| | - Chris Orvig
- Medicinal Inorganic Chemistry Group, Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada
| |
Collapse
|
499
|
Adeowo FY, Honarparvar B, Skelton AA. Density Functional Theory Study on the Complexation of NOTA as a Bifunctional Chelator with Radiometal Ions. J Phys Chem A 2017; 121:6054-6062. [PMID: 28737914 DOI: 10.1021/acs.jpca.7b01017] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
1,4,7-Triazacyclononane-1,4,7-triacetic acid (NOTA) is a key bifunctional chelator utilized for the complexation of metal ions in radiopharmaceutical applications; the ability of these chelators depends on the strength of their binding with ions. The focus of the present work is to evaluate the complexation of Cu2+, Ga3+, Sc3+, and In3+ radiometal ions with NOTA using density functional theory (B3LYP functional) and 6-311+G(2d,2p)/DGDZVP basis sets. The significant role of ion-water interactions in the chelation interaction energies in solution reflects the competition between ion-water and NOTA-ion interaction in the chelation process. There is reasonable agreement between experimental and theoretical binding constants, geometries, and 1H NMR chemical shifts. Chelation interaction energies, Gibbs free energies, and entropies in solution show that the NOTA-Ga3+ and NOTA-Cu2+ are the most and least stable complexes, respectively. The natural atomic charges and second order perturbation analysis reveal charge transfer between NOTA and radiometal ions. The theoretical 1H NMR chemical shifts of NOTA are in good agreement with experiment; these values are influenced by the presence of the ions, which have a deshielding effect on the protons of NOTA. Global scalar properties such as EHOMO/ELUMO, ΔELUMO-HOMO, and chemical hardness/softness confirm that the NOTA-Cu2+ complex, which has a singly occupied molecular orbital, has the lowest ΔELUMO-HOMO value, the least chemical hardness, and the highest chemical softness. The significant variation of the hardness and ΔELUMO-HOMO values of the complexes can be attributed to the different positions of the metal ions on the periodic table. This study affirms that, among the radiometal ions, Ga3+ can be used to effectively radiolabel NOTA chelator for radiopharmaceutical usage as it binds most stably with NOTA.
Collapse
Affiliation(s)
- F Y Adeowo
- School of Health Sciences, Discipline of Pharmacy, University of KwaZulu-Natal , Durban 4001, South Africa
| | - B Honarparvar
- School of Health Sciences, Discipline of Pharmacy, University of KwaZulu-Natal , Durban 4001, South Africa
| | - A A Skelton
- School of Health Sciences, Discipline of Pharmacy, University of KwaZulu-Natal , Durban 4001, South Africa
| |
Collapse
|
500
|
Cole EL, Kim J, Donnelly DJ, Smith RA, Cohen D, Lafont V, Morin PE, Huang RYC, Chow PL, Hayes W, Bonacorsi S. Radiosynthesis and preclinical PET evaluation of 89Zr-nivolumab (BMS-936558) in healthy non-human primates. Bioorg Med Chem 2017; 25:5407-5414. [PMID: 28803798 DOI: 10.1016/j.bmc.2017.07.066] [Citation(s) in RCA: 64] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2017] [Revised: 07/25/2017] [Accepted: 07/31/2017] [Indexed: 11/30/2022]
Abstract
Cancer immunotherapy, unlike traditional cytotoxic chemotherapeutic treatments, engages the immune system to identify cancer cells and stimulate immune responses. The Programmed Death-1 (PD-1) protein is an immunoinhibitory receptor expressed by activated cytotoxic T-lymphocytes (CTL) that seek out and destroy cancer cells. Multiple cancer types express and upregulate the Programmed Death-Ligand 1 (PD-L1) and 2 (PD-L2) which bind to PD-1 as an immune escape mechanism. Nivolumab is a fully human IgG4 anti-PD-1 monoclonal antibody (mAb) approved for treatment of multiple cancer types. This study reports the preparation and in vivo evaluation of 89Zr labeled nivolumab in healthy non-human primates (NHP) as a preliminary study of biodistribution and clearance. The radiochemical and in vivo stabilities of the 89Zr complex were shown to be acceptable for imaging. Three naïve NHPs were intravenously injected with tracer only or tracer co-injected with nivolumab followed by co-registered by positron emission tomography (PET) and magnetic resonance imaging (MRI), acquired for eight days following injection. Image-derived standardized uptake values (SUV) were quantified by region of interest (ROI) analysis. Radioactivity in the spleen was significantly reduced by addition of excess nivolumab compared to the tracer only study at all imaging time points. Liver uptake of the radiotracer was consistent as a clearance organ with minimal signal from other tissues: lung, muscle, brain, heart, and kidney. The results indicate specific biodistribution to the spleen, which can be blocked by co-administration of excess nivolumab. Distribution to other organs is consistent with elimination pathways of antibodies, with primary clearance through the liver.
Collapse
Affiliation(s)
- Erin L Cole
- Radiochemistry Group, Bristol-Myers Squibb Company, Princeton, NJ, USA.
| | - Joonyoung Kim
- Imaging Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - David J Donnelly
- Radiochemistry Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - R Adam Smith
- Imaging Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Daniel Cohen
- Protein Science Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Virginie Lafont
- Protein Science Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Paul E Morin
- Protein Science Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Richard Y-C Huang
- Bioanalytical and Discovery Analytical Sciences, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Patrick L Chow
- Imaging Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Wendy Hayes
- Imaging Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| | - Samuel Bonacorsi
- Radiochemistry Group, Bristol-Myers Squibb Company, Princeton, NJ, USA
| |
Collapse
|